PAMJ Supplement - Call for papers

Not displayed properly? View this announcement online - Please do not respond directly to this email. Address queries to editor@panafrican-med-journal.com

Add pamj.alert@panafrican-med-journal.com to your safe senders list in your e-mail address book. Doing so ensures that our e-mails reach your Inbox. Thank you.

Supplement: The Future of Immunization in Africa - Now accepting submissions

The Pan African Medical Journal invites now accepts submissions for the upcoming supplement “The Future of Immunization in Africa”.
Guest editors: Bob Davis (Am Red Cross) , Helen Rees (Wits U) and Steve Cochi (GID, CDC)
Submit your contribution by 31 December 2016
Publication expected in April 2017

About this supplement

Immunization is undoubtedly one of the most successful and cost effective public health interventions of all time. It is estimated that between two to three millions deaths from diseases such as diphtheria, measles, pertussis, pneumonia, polio, rotavirus diarrhoea, rubella and tetanus are prevented every year. Since its inception in Africa in the late 1970s, the Expanded Program on Immunization (EPI) has undergone major transformations. From the six diseases targeted by EPI in the early 70s, additional vaccines have been added; most countries have now introduced Hepatitis B, Haemophilus influenzae type b (Hib), rotavirus, pneumococcal, rubella and HPV vaccines. New financial mechanisms, renewed commitments by governments, donors and regional bodies, new vaccine and technology developments and the eradication of polio finally in sight, augur a bright future for immunization in Africa. What have been and what will be the transformative forces for immunization in africa? This is what the supplement "The Future Of Immunization in Africa" is about.

Guest editors

Robert (Bob) Davis, American Red Cross Delegate for Immunization in Africa, Nairobi, Kenya

Dr Steve Cochi, Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA, USA

Prof Helen Rees, University of Witwatersrand, Former member and Chair Person of SAGE, SA

Manuscripts addressing the following broad range of topics will be considered:

New vaccine delivery technologies or vaccine formulations and their potential impact in improving adherence or acceptance of vaccine
Routine immunization in the local, regional and global context, including regional and global commitments
Novel approaches or country experience in improving routine vaccination coverage and reducing drop-outs
Countries challenges in reaching and sustaining vaccine independence
Status of current elimination initiatives (MNTE, Measles, Rubella)
EPI beyond 9 months or second year of live (2YL) opportunities
Field evaluations of solar cold chain and other cold chain technology
Vaccination of nomads and other hard to reach populations
Social mobilization and vaccine hesitancy in routine immunization
Country level costing studies and vaccine financing
Role of new softwares, especially cell phone applications, in routine immunization and campaigns

The manuscripts will be considered under the categories: original research, Case studies, Commentary, Opinion, letter to the editors, Editorials. Publication charges will be waived for accepted manuscripts.

Manuscript requirements: Are available on the journal instructions for authors (www.panafrican-med-journal.com/instruction.php) - Submit your manuscript under the category Supplement-EPI 2017

If you have questions about this supplement, send an email to: Bob Davis (kidsurvival@gmail.com), Steve Cochi (slc1@cdc.gov) or Helen Rees (hrees@wrhi.ac.za). For all other requests or inquiries, send an email to editor@panafrican-med-journal.com.

Terms and conditions | Privacy statement | Contact technical board | RSS feeds